About this trial
The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients (i.e., patients ≥18 years of age) with diagnosed SE between 2005 and 2023 who have been treated at the University Hospital of Basel or the Cantonal Hospital Aarau.
Disqualifiers
Patients younger than 18 years.
Patients with repetitive epileptic seizures not qualifying for SE.
Patients with documented refusal of the general consent.
Trial population
Adult patients (i.e., patients ≥18 years of age) with SE treated at the University Hospital Basel and the Cantonal Hospital Aarau.
Trial design
Cohort
Retrospective
Treatments tested in this trial
collection of patient data
Other interventionExtract data from the digital medical records, the electroencephalographic and microbiologic database.
Treatment groups
Trial outcomes
Primary outcomes
Demographics
age, sex
Data from acute prehospital management by the emergency medical services (EMS)
extracted from the treatment protocols of the EMS
Duration of ICU (intensive care unit) and hospital stay, and destination at discharge
Duration of ICU (intensive care unit) and hospital stay, and destination at discharge
Date(s) of seizure(s) captured by electroencephalographic (EEG) data
Date(s) of seizure(s) captured by EEG
Sponsors and contacts
Click on the lead sponsor to view all of their trials.